When COVID-19 vaccines were first authorized in Dec. 2020 and it was discovered blood clotting disorders were occurring in the vaccinated, researchers began analyzing blood samples of patients to determine what within a COVID vaccine could be contributing to blood coagulation disorders. Numerous researchers in Spain, Germany, Korea, Brazil and South Africa started testing the […]
Moderna
White House Prepares Americans to Roll Up Their Sleeves for Annual COVID-19 Booster Shots That Don’t Work
The White House announced on Tuesday that Americans will likely need to receive an annual COVID-19 booster shot because previous doses of “safe and effective” COVID vaccines worked so well. Worded in a cleverly strategic way to make it sound like we are receiving a gift we actually want, the White House said Americans may […]
FDA Authorizes Modified COVID Boosters Without Human Clinical Trials
The Food and Drug Administration (FDA) on Wednesday authorized modified COVID-19 booster shots without requiring any human clinical trials to be completed to determine the safety or efficacy of the experimental shots. “We have worked closely with the vaccine manufacturers to ensure the development of these updated boosters was done safely and efficiently. The FDA […]
Moderna Sues Pfizer and BioNTech for Allegedly Copying mRNA Technology Used in COVID Vaccine
Moderna on Aug. 26 announced it had filed a lawsuit against Pfizer and BioNTech for allegedly infringing upon patents Moderna filed between 2010 and 2016 for its mRNA technology. “Today [Moderna is] filing patent infringement lawsuits against Pfizer and BioNTech in the United States District Court for the District of Massachusetts and the Regional Court […]
FDA Plans to Base Authorization of New COVID Boosters on Studies of Mice, Not Humans
The U.S. Food and Drug Administration (FDA) has officially lost its mind. The agency has adopted a controversial strategy to evaluate the new bivalent Omicron COVID-19 boosters scheduled to be rolled out in September. The FDA has decided it will base its decision on whether to authorize the new boosters — developed just five minutes […]